MAPT and Alzheimer disease: Furthermore, this observation has also been reported in a transgenic AD mouse model expressing mutant tau P301L and in both human and mouse fibroblasts exposed to apolipoprotein E (ApoE4), a major risk factor for developing SAD 85, 86.